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Supplementary Figure S1 Theophylline dependence of in-line cleavage at C56 (■) and C74 (○) of S4t. Individual bands from the in-
line gel (Figure 1B) were quantified and normalized to an adjacent constant region to remove bias from inconsistent well loading. 
C56 bands were normalized to U47 bands, while C74 bands were normalized to U100-G102 bands. Curves were fit using a standard 
Michaelis-Menten model, with determined KD values of 3.6 µM and 6.8 µM for C56 and C74, respectively.
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Supplementary Figure S2 Antisense inhibition of guide strand activity represses RNAi-mediated silencing of GFP. Cells stably 
expressing EGFP were cotransfected with the designated oligo and a plasmid that expresses a scrambled shRNA (neg), shRNA 
switch S1, or an shRNA targeting a different region of the EGFP mRNA (sh’). Mean fluorescence relative to neg are based on flow 
cytometry measurements of transfected cells. The guide strands are shown in green, 2’-O-Methyl nucleotides in black, and deoxy
nucleotides in blue. Error bars represent one standard deviation from duplicate transfected wells.
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Supplementary Figure S3 Functionality of shRNA switches in different cell lines. Cells lacking endogenous EGFP expression were 
cotransfected with the shRNA construct and an EGFP expression plasmid in the presence (■) or absence (□) of 3 mM theophylline. 
Mean fluorescence values were normalized to red fluorescence values (DsRed-Express) contributed by the shRNA construct. These 
values were then normalized to those of cells transfected with a scrambled shRNA (neg). Error bars represent one standard 
deviation from triplicate transfected wells. 
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Supplementary Figure S4 Derived model equation and model fit of theophylline response curve for S1 data. See 
Supplementary Text 1 for model derivation. The value of fshRNA was set by a separate transfection experiment with the original
shRNA targeting EGFP (sh) under the same conditions. The value of e was determined from the average basal expression levels 
of shRNA switches that highly favor the active conformation (S5, S7, S9, S10). Parameters KComp, KApt and h were produced by a 
least-squares fit (—) to the S1 data (●). Parameter values are reported to the right of the plot.
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Supplementary Figure S5 Depiction of methods to calculate ΔG from shRNA switch sequence information. Base-pairing 
probabilities of base-pairs designated by arrows were used for the PF method. The boxed sections designate the major stem in the 
active and inactive conformations used under the Stems method.
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Supplementary Figure S6 Alternative methods to relate shRNA switch sequence and in vivo basal expression levels. ΔG was 
calculated (ΔGmethod) for shRNA switches S1-10 using RNA secondary structure prediction algorithms. Plots relating ΔGmethod and 
measured basal expression level for shRNA switches S1-10, where ΔG was calculated using the MFE method or the PF method. A 
three-parameter equation with the same mathematical form as the model was fit by least-squares analysis to each data set.
Supplementary Figure S7 Theophylline response curve for the initial (S1, ●) and optimized (S13, ●) shRNA switches. Median 
fluorescence values from flow cytometry analysis were normalized to that of untransfected cells in the same well. Error bars 
represent one standard deviation from duplicate transfected wells.
Supplementary Figure S8 Theophylline-mediated gene regulation of endogenous La protein with shRNA switches. (A) qRT-PCR 
of La protein mRNA from HEK293T tTA-d2EGFP cells transfected in the presence (■) or absence (□) of 1.5 mM theophylline. 
Calculated free energy differences from the ‘Stems,’ MFE, and PF methods are displayed below each shRNA switch. Our model 
predicts decreasing basal levels for increasing bias toward the active conformation (higher values of ΔGmethod). Coefficient of 
determination (R2) for each method is included. Error bars represent quadruplicate qRT-PCR measurements. (B) Curve fit to 
extrapolate empirical parameters C1-3 using the ‘Stems’ method using a least-squares fit. Dashed line marks knockdown achieved 
by base shRNA. 
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Supplementary Figure S9 Representative histograms 
and dot plots for HEK293T tTA-d2EGFP cells transiently 
transfected with a plasmid expressing DsRed-Express and 
either a scrambled shRNA (Scr), the base shRNA 
targeting EGFP (sh), or shRNA switch S13. Gates in the 
histogram capture the transfected (H) and untransfected 
(L) populations in each well, where the unstransfected
gate was set based on a mock-transfected control that 
was below the limit of detection (data not shown). The two 
bottom rows show the resulting GFP histograms on linear 
or logarithmic axes for the transfected (▬) and 
untransfected (▬) gates. The calculation of GFP(%) used 
in the main text is shown on the right. Median GFP levels 
of each transfected population were normalized to that of 
untransfected cells in the same well, thereby reducing 
well-to-well variability. As compared to the mean, the 
median of each histogram gave more consistent results for 
the transient assays.
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Supplementary Table I shRNA and shRNA switch sequences. Color schemes correspond to Figure 1A. 
Oligos are written from 5’ to 3’ and reflect the insert sequence cloned into the base plasmid. L1-6 were 
cloned into shL, while all other switch sequences were cloned into sh. 
Name Aptamer Sequence Cloning sites (5'/3') Database # 
neg GGATCCACTACCGTTGTTATAGGTGTTCAAGAGACACCTATAACAACGGTAGTTTTTTGGAAAAGCTT pCS628 
sh 
GGATCCGGTGCAGATGAACTTCAGGGTCAGCTCGA
GTCTAGAGCTGACCCTGAATCATCTGCACCTTTTTT
GGAAGCTT 
pCS741 
shL 
N
/A
 
GGATCCGGCTTCCCAACGATGATGCAACTCCTCGA
GTCTAGAGGAGTTGCATCAGTTGGGAAGCCTTTTTT
GGAAGCTT 
BamHI/HindIII 
pCS1457 
          
S1 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGGGCTGACCCTGACTAGA pCS630 
S1' CTCGAGGACCCAGCATCGACTCTTCGATGCAAATGGCAGCTCGGGCTGACCCTGACTAGA pCS847 
S2 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGGGCTGACCCTGAAGCTAGA pCS633 
S3 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGGGCTGACCCTGAACTAGA pCS631 
S4 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGGGCTGACCCTGCTAGA pCS628 
S5 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGGGCTGACCCTCTAGA pCS632 
S6 CTCGACGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCGTCGGGCTGACCCTGCTAGA pCS848 
S7 CTCGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCGAGCTGACCCTGCTAGA pCS807 
S8 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGAGCTGACCCTGCTAGA pCS629 
S9 CTCGAGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCTCGAGCTGATCCTGCTAGA pCS1005 
S10 CTCGATACCAGCATCGACTCTTCGATGCCCTTGGCAGCGAGCTGACCCTGACTAGA pCS808 
S11 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGGGCTGACCCTGACTAGA pCS634 
S12 CTCGAGATACCACCGAAAGGCCTTGGCAGCTCGGGCTGACCCTGACTAGA pCS635 
S13 
th
eo
ph
yl
lin
e 
CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCG
GGCTGACCCTGCTAGA 
XhoI/XbaI 
pCS911 
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Supplementary Table I cont’d. 
Name Aptamer Sequence Cloning sites (5'/3') Database # 
S14 CTCGATACCAGCCGAAAGGCCCTTGGCAGCGAGCTGACCCTGCTAGA pCS908 
S15 CTCGATACCAGCCGAAAGGCCCTTGGCAGCGGGCTGACCCTGCTAGA pCS909 
S16 CTCGATACCAGCCGAAAGGCCCTTGGCAGCGAGCTGACCCTGACTAGA pCS910 
S17 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGAGCTGACCCTGCTAGA pCS941 
S18 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGAGCTGACCCTACTAGA pCS942 
S19 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGGGCTGACCCTGAACTAGA pCS1001 
S20 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGGGCTGACCCTGAAGCTAGA pCS1002 
S21 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGGGCTGACCCTGGCTAGA pCS1003 
S22 CTCGATACCAGCCGAAAGGCCCTTGGCAGCGAGCTGACCCTGAACTAGA pCS1004 
S23 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGAGCTGATCCTGCTAGA pCS1061 
S24 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGGGCTGATCCTGCTAGA pCS1062 
S25 
th
eo
ph
yl
lin
e 
CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCG
GGCTGATCCTGACTAGA 
XhoI/XbaI 
pCS1063 
          
X1 CTCGAGTGTATTACCCAGCGAGGTCGACTCGAGCTGACCCTGACTAGA pCS870 
X1' CTCGAGTTTCAAACCCAGCGAGGTACACTCGAGCTGACCCTGACTAGA pCS913 
X2 CTCGAGTGTATTACCCAGCGAGGTCGACTCGAGCTGACCCTGAACTAGA pCS972 
X3 
xa
nt
hi
ne
/g
ua
ni
ne
 
CTCGAGTGTATTACCCAGCGAGGTCGACTCGAGCT
GACCCTGCTAGA 
XhoI/XbaI 
pCS869 
          
T1 
te
tra
cy
cl
in
e 
CTCGAAAACATACCAGAGAAATCTGGAGAGGTGAA
GAATACGACCACCTCGAGCTGACCCTGCTAGA XhoI/XbaI pCS895 
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Supplementary Table I cont’d. 
Name Aptamer Sequence Cloning sites (5'/3') Database # 
L1 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGAGGAGTTGCATCCTAGA pCS1458 
L2 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGAGGAGTTGCATTCTAGA pCS1459 
L3 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTTGAGGAGTTGCATCCTAGA pCS1460 
L4 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTTGAGGAGTTGCATACTAGA pCS1462 
L5 CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTCGAGGAGTTGCACTAGA pCS1463 
L6 
th
eo
ph
yl
lin
e 
CTCGAGATACCAGCCGAAAGGCCCTTGGCAGCTTG
AGGAGTTGCACTAGA 
XhoI/XbaI 
pCS1464 
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Supplementary Table II Calculated free energies and corresponding expression 
levels of theophylline-regulated shRNA switches. η: ratio of relative GFP levels at 
exogenous theophylline concentrations of 3 mM and 1 µM for each shRNA switch.  
ΔG (method) 
Name Aptamer Basal expression levels (%) η 
MFE PF Stems 
neg 90.7 1.07 N/A 
sh 
N
/A
 
4.6 1.19 N/A 
              
S1 33.8 2.71 -0.1 0.6 -5.1 
S1' 37.0 1.39 -0.3 0.8 -5.1 
S2 76.7 1.25 0.0 -0.2 -8.6 
S3 52.8 1.68 -0.6 -0.1 -6.1 
S4 23.8 3.65 3.2 3.4 -3.2 
S5 21.1 3.58 6.2 6.2 -0.6 
S6 42.5 2.20 2.1 2.7 -5.7 
S7 14.5 2.32 2.5 3.2 0.4 
S8 37.3 2.47 0.3 1.2 -4.1 
S9 12.1 4.75 2.9 3.2 -1.5 
S10 29.4 3.60 -0.9 -0.1 -1.5 
S11 20.0 4.20 0.6 0.9 -5.1 
S12 13.4 4.06 -0.1 0.8 -5.1 
S13 16.7 5.61 4.0 3.8 -3.2 
S14 14.3 2.86 2.6 3.3 0.4 
S15 
th
eo
ph
yl
lin
e 
11.2 2.56 9.9 9.1 1.3 
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Supplementary Table II cont’d. 
ΔG (method) 
Name Aptamer Basal expression levels (%) η 
MFE PF Stems 
S16 21.7 3.85 0.1 0.1 -1.5 
S17 17.5 3.12 2.5 2.0 -4.1 
S18 19.5 3.89 5.7 4.5 -1.5 
S19 38.3 2.38 -0.6 0.0 -6.1 
S20 49.8 1.75 0.0 -0.2 -8.6 
S21 10.8 2.52 4.6 4.6 -4.2 
S22 35.0 2.73 -0.9 -0.9 -2.4 
S23 16.6 3.30 5.1 4.4 -1.5 
S24 10.8 3.00 6.6 6.1 -0.6 
S25 
th
eo
ph
yl
lin
e 
11.8 2.63 3.2 3.3 -2.5 
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DERIVATION OF MATHEMATICAL MODEL 
 
We initially developed a mathematical model to examine the mechanism through which 
shRNA switches mediate ligand control of RNA interference (RNAi). Instead of drawing 
from existing models (Bartlett and Davis, 2006; Malphettes and Fussenegger, 2006; Raab 
and Stephanopoulos, 2004) that take into account the mechanistic steps and kinetics of 
RNAi that are well characterized, we chose to derive a simplified model that captures the 
steady-state behavior of shRNA switches and the fundamental mechanism that provides 
for ligand regulation of gene expression. The goal was to develop a model that predicts 
the relative steady-state expression levels of the target gene (f; output) as a function of 
exogenous ligand concentration (L; input) and can be easily adapted to predict shRNA 
switch activity in different cellular environments. 
To accomplish this we first began with the proposed mechanism for shRNA 
switch functionality (Figure 1A). This mechanism asserts that a single shRNA switch can 
adopt two conformations due to distinct base-pairing interactions. The active 
conformation (left) is processed by the RNAi machinery to an siRNA that initiates RNAi-
mediated silencing of target transcripts. Processing includes nuclear export by Exportin-5 
(Yi et al, 2003) and cleavage by the RNase III-like enzyme Dicer (Ketting et al, 2001). 
Conversely, the inactive conformation (middle) is not processed by the RNAi machinery. 
Ligand binding to the formed aptamer domain in the inactive conformation stabilizes this 
conformation (right), thereby reducing overall processing of the shRNA switch to an 
siRNA. 
Model derivation began by assuming that the three conformations (active, 
inactive, and inactive bound to ligand) are at thermodynamic equilibrium as determined 
by KComp and KApt. KComp is the equilibrium partitioning constant between active and 
inactive conformations, while KApt is the association constant for binding between ligand 
and the inactive conformation. When normalized to the total shRNA switch 
concentration, the fraction of shRNA switches in the active conformation is 
 1
( )LK1K1 1     aptcomp ⋅++=⎥⎦
⎤⎢⎣
⎡
(1) . 
   
 The next step was correlating the fraction of shRNA switches in the active 
conformation to relative expression levels of the target gene. Previous models have 
highlighted the importance of absolute expression levels of the RNAi substrate, target 
gene transcripts, and the RNA-induced silencing complex (RISC), as well as the rate of 
cell division (Bartlett et al, 2006). Recent work has elaborated on the mechanism of 
RNAi, including the emerging role of Dicer binding partners TRBP and PACT (Gregory 
et al, 2005; Kok et al, 2007; Lee et al, 2006), association of RISC and Dicer (Gregory et 
al, 2005), shuttling of the cleaved siRNA from Dicer to RISC (Gregory et al, 2005), 
cleavage and release of the passenger strand (Matranga et al, 2005; Rand et al, 2005), 
target site availability for efficient degradation of the target transcript (Westerhout and 
Berkhout, 2007), and the potential for saturation of Exportin-5 (Grimm et al, 2006; Yi et 
al, 2005). Rather than offer a descriptive model of RNAi that incorporates all of these 
mechanisms that are still under investigation, we chose an empirical route that requires 
minimal experimental data. 
 Excluding nuclear export by Exportin-5, the mechanistic steps described above 
apply to the linear cascade downstream of and including Dicer recognition and 
processing. Incorporation of three parameters, fshRNA, e, and h, can account for the 
dynamics of these steps. fshRNA is the relative knockdown achieved by the original shRNA 
– an RNA molecule comprised of a loop region and the shRNA stem sequence, e is the 
efficiency of shRNA switch processing by the RNAi machinery, and h is the hill 
coefficient that accounts for the nonlinearity between the concentration of Dicer-cleaved 
siRNAs and relative expression levels of the target gene. To capture the correlation 
between the prevalence of the active conformation and target gene expression levels, we 
used the following relationship: 
 
h 
shRNA
     
fe1   f ⎥⎦
⎤⎢⎣
⎡⋅−= (2) . 
Introducing equation (1) into equation (2) yields the final form of the model: 
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where the relative expression levels of the target gene (f) are a function of exogenous 
ligand concentration (L).  
 The power of our model lies in the ability to calculate realistic parameter values 
from a minimal set of experiments: fshRNA can be found in one experiment by measuring 
the relative knockdown of the target gene induced by an shRNA that contributes the 
shRNA stem, e can be calculated from basal expression levels from a few shRNA 
switches that strongly prefer the active conformation, and h can be calculated by 
generating a ligand response curve with one shRNA switch – as long as administration of 
the highest ligand concentration results in negligible knockdown of the target gene. The 
remaining model parameters, KComp and KApt, can be found from the same response curve 
used to calculate e, since varying KApt only changes the EC50 while varying KComp 
changes both EC50 and basal expression levels. A summary of the model parameters and 
how values are experimentally obtained are included in Table III below. 
  
Table III Description of model parameters 
parameter initial determination description 
KComp fit to data Equilibrium partitioning constant between 
conformations equal to [inactive]/[active] (-) 
KApt fit to data Association constant between ligand and formed 
aptamer (1/μM) 
e extrapolated from data RNAi processing efficiency (-) 
fshRNA from shRNA data Relative knockdown by original shRNA (-) 
h fit to data Hill coefficient (-) 
 
 
To investigate the validity of the model, we experimentally determined model 
parameter values as described above: fshRNA was equated to the knockdown achieved with 
the original shRNA targeting EGFP (sh); e was calculated from the average basal 
expression levels produced by shRNA switches S5, S7, S9, and S10; and KComp, KApt, and 
 3
h were determined by a model fit of the theophylline response curve for S1. The resulting 
parameter values are shown in Supplementary Figure S4. The fit curve aligns with the 
response curve for S1, and the fit parameter values are realistic as described below for 
KApt and KComp. The EC50 is related to KApt and KComp according to the following: 
 
(4) , ( ) -1Apt-1Comp50 KK1 EC +=
From the in-line assay results, the ratio of the apparent KD of S4t (5 µM) to the KD of the 
aptamer alone (0.29 µM (Zimmermann et al, 2000)) was ~ 17. Solving for KComp in 
equation (4) yields a value of 0.06. While this is below the fit value from the S1 data of 
0.17, S1 has one less base pair than S4 contributed by the competing strand. Thus, the 
value from S4t is anticipated to be closer to 0.17 if the extra base pair is included. The fit 
value for KApt (0.016 µM-1) from the S1 data was lower than that for the aptamer alone 
(3.4 µM), which can be attributed to a theophylline concentration drop across the cellular 
membrane as observed in E. coli (Koch, 1956) and S. cerevisiae (J Liang, J Michener, C 
Smolke, unpublished data, 2008). Hence the model faithfully follows the underlying 
mechanism of ligand regulation of gene expression mediated by shRNA switches and can 
capture in vivo behavior by utilizing a minimal set of experiments. 
 4
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Supplementary Text 2 
 
FREE ENERGY CALCULATIONS AND MODEL EXTENSION 
 
The model derived in Supplementary Text 1 identified different tuning trends that were 
observed in our experimental analysis, although this form of the model only predicts 
qualitative shifts in the transfer function based upon nucleotide changes to a parent 
shRNA switch. We sought to augment the model with predictive capabilities for the 
forward design of shRNA switch sequences that yield desired transfer functions. We 
initially focused on KComp, the equilibrium partitioning constant between active and 
inactive conformations, since it solely captured the effect of multiple changes to the 
competing strand and has a thermodynamic basis. Under basic thermodynamic 
assumptions, KComp is related to the free energy difference (ΔG) between the active and 
inactive conformations according to 
 
 , ( )CompBA KlnTkN     E     EΔG ⋅−=⎟⎟⎠
⎞
⎜⎜⎝
⎛−⎟⎟⎠
⎞
⎜⎜⎝
⎛= (1) 
where NA is Avogadro’s number, kB is the Boltzmann constant, and T is temperature (K). 
If ΔG can be calculated for a given shRNA switch sequence, then the corresponding 
value of KComp can be calculated. When paired with the other experimentally-determined 
parameter values (Supplementary Text 1), this value of KComp can then be used in the 
model to predict the transfer function relating ligand concentration and relative gene 
expression levels. The initial challenge is calculating an experimentally valid ΔG from a 
given shRNA switch sequence. 
 
Free energy calculation  
To calculate ΔG, we employed the RNA secondary structure prediction program 
RNAStructure 4.5 (Mathews et al, 2004) to output structural and energetic information 
for a given sequence. The program’s dynamic folding algorithm utilizes empirical energy 
values measured in vitro (Mathews et al, 2004) to predict RNA conformations and their 
 1
relative free energy. Since application of the program to in vivo folding has rarely been 
addressed (Mathews et al, 2004), we first asked if ΔG values calculated from the program 
(ΔGmethod) correlated with measured basal expression levels for each shRNA switch. Two 
commonly used methods were initially employed to calculate ΔGmethod for S1-10 
(switches with the same aptamer domain and shRNA stem): minimal free energy of the 
active and inactive conformation (MFE method) and partition function calculation to find 
the relative probability of either general conformation (PF method). ΔGmethod values were 
then plotted with the associated basal expression levels measured in vivo (Supplementary 
Table II) and compared to the expected trend from the model (ΔGmodel; Figure 6B). A 
three-parameter equation with the same mathematical form as the model was then fit to 
each data set using a least-squares analysis to evaluate the correlation strength, since a 
strong correlation is necessary for accurate prediction of the transfer function. The 
mathematical form used to fit the data was 
 
 , (2) 
3C- 
AB
method
21fit TNk
ΔG
expC C1   f ⎥⎦
⎤⎢⎣
⎡
⎟⎟⎠
⎞
⎜⎜⎝
⎛−+−=
where C1 , C2 , and C3 are fit constants and ffit is the basal expression of the target gene 
for the fit curve. 
 
MFE method 
The minimal free energy conformation – the most stable conformation – has been 
considered to be representative of the actual tertiary structure, and the free energy of this 
conformation is often considered to represent overall energetics of the RNA sequence. 
Under the MFE method, the free energy is recorded for the most stable active and 
inactive conformation. The difference in these free energy values is then reported as 
ΔGmethod. The resulting plot (Supplementary Figure S6) shows no significant correlation 
and an associated weak fit (R2 = 0.35), suggesting that this method is insufficient for 
predicting transfer functions. 
 
 
 
 2
PF method 
Calculation of the partition function is a more advanced and considered to be a more 
accurate method for the approximation of RNA energetics. All possible secondary 
structure conformations and their energies are calculated in order to identify the most 
prevalent conformation, which often deviates from the minimal free energy 
conformation. Under the PF method, the program outputs the probability of a given base-
pair based on the partition function calculation. To convert these probabilities into a value 
of ΔG, we first found the smaller value of the base-pair probabilities near the top and 
bottom of the upper shRNA stem (starting at the stem bulge) in the active conformation 
and the stem formed by the competing strand and the shRNA stem in the inactive 
conformation (Supplementary Figure S5). Base-pairs were chosen such that the same 
nucleotide in the shRNA stem was part of the selected base-pair in both conformations. 
This ensures that a base-pair probability only applies to one of the two conformations. In 
other words the sum of the base-pair probabilities that include the same nucleotide for 
both conformations should always be less than one. Ideally, the sum should equal one, 
where all calculated sums for S1-10 were between 85% and 99% (data not shown). The 
value of ΔGmethod can be calculated from the base-pair probabilities according to the 
following: 
 
 , (3) ⎟⎟⎠
⎞
⎜⎜⎝
⎛⋅=
A
I
ABmethod P
P
lnTNk-   ΔG
where PA and PI are the base-pair probabilities representing the active or inactive 
conformations, respectively. ΔGmethod values were calculated using the PF method and 
plotted in the same way as above (Supplementary Figure S6). The PF method provided a 
better fit (R2 = 0.53) when compared to the MFE method that qualitatively matched the 
model trend, although the fit is not suitable for predictive purposes. 
 
Stems method 
While increasing the extent of base-pairing between the competing strand and shRNA 
stem always resulted in an increase in basal expression levels (Figure 3B-G), the MFE 
and PF calculations output predicted an increase or decrease in free energy changes based 
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on binding interactions outside of the major stems. We attributed the inaccuracy of the 
MFE and PF methods to the equal weight placed on these binding interactions. To 
remove these contributions to the energetic calculation, we devised a third method we 
term the ‘Stems’ method. This method only accounts for the energetic contributions from 
the major stems in the active and inactive conformations. The major stem for the active 
conformation spans from the shRNA stem bulge to the top of the shRNA stem, while the 
major stem for the inactive conformation includes base-pairs formed between the shRNA 
stem and the competing strand (Supplementary Figure S5). The lower portion of the 
shRNA stem is ignored since it is present in both conformations. As before, we calculated 
ΔGmethod for S1-10 and plotted these values against the basal expression levels. The 
resulting plot (Figure 6C) shows a strong correlation (R2 = 0.94), a significant 
improvement over the other methods. 
 It is surprising yet insightful that the most accurate method only accounts for 
energetic contributions from regions that interact with the competing strand, which is 
precisely and solely where KComp maps. An inequality does exist between the fit curve 
from the ‘Stems’ method and model predictions in terms of the abscissa values and curve 
slope, which suggests that sequences outside of the major stem contribute to folding 
energetics in vivo in a way that is improperly treated by the MFE or PF method.  
 
Model extension 
Based on the strong correlation between ΔGmethod calculated from shRNA switch 
sequence and in vivo basal expression levels, the fit curve from the ‘Stems’ method can 
be incorporated into our model for the forward design of shRNA switches. This is 
accomplished by converting the value of ΔGmethod calculated from the ‘Stems’ method 
into KComp that can be used in the model to predict the transfer function. To perform this 
conversion, f from the model equation and ffit from the curve fit are set equal to each 
other. For successful conversion, the dynamic range (the range of f) of the model and fit 
curves must match exactly. This can be done by ensuring that 
 
 , (4) ( )∞→=⋅ methodfitshRNA ΔGf   fe-1
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where e and fshRNA are model parameters. Once set equal to each other, KComp can be 
found in terms of ΔGmethod: 
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 Replacing KComp in the model with equation (5) yields the extended model: 
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Following experimental determination of the remaining model parameter values 
(Supplementary Text 1), this equation can be used to predict relative expression levels of 
the target gene (fmodel) as a function of ligand concentration (L) by calculating ΔGmethod 
under the ‘Stems’ method using RNAStructure. 
Since the obtained fit parameter values are specific to shRNA switches S1-10, 
there is a question as to how parameter values and model accuracy will change for a new 
aptamer, target sequence, or cellular context. To address the generality of the model, we 
constructed six shRNA switches (L1-6) targeting the endogenous La protein that covered 
a range of values for ΔGmethod. Cells were transiently transfected with plasmids harboring 
each shRNA in the presence or absence of theophylline and assayed for La levels by 
qRT-PCR (Figure 7, Supplementary Figure S8). Parameter values C1-3 were again 
extrapolated through a least-squares fit of the basal expression data for L1-6. Similar to 
the GFP-targeting shRNA switches, a strong correlation was determined using the 
‘Stems’ method, which was not observed with the MFE and PF methods, that yielded a 
relationship between dynamic range and ΔGmethod closely matching experimental results. 
However, the predicted relationship between ΔGmethod and dynamic range was slightly 
shifted as compared to that generated from the fit parameter values for S1-10 
supplemented with the shRNA potency (fshRNA) and aptamer inhibitory effect (e) 
determined for the La-targeting shRNA switches. The parameters fshRNA and e were 
calculated using basal levels from the base shRNA (shL) and an shRNA switch (L6) 
strongly biased toward the active conformation, respectively. The results suggest that the 
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‘Stems’ method is suitable for the prediction of shRNA switch behavior in vivo when 
supplemented with empirical parameter values specific to each shRNA stem sequence. 
As demonstrated here the parameter values can be determined from the basal expression 
levels of only a few switches. As our understanding of dynamic RNA behavior in vivo 
progresses, future modeling efforts may provide more accurate methods that move 
toward de novo sequence-function prediction. 
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Supplementary Methods 
 
Antisense inhibition of RNAi. Oligonucleotides were chemically synthesized 
(Integrated DNA Technologies) with 3’ amino linkers (L). The following sequences were 
used, where 2’-O-methyl nucleotides are underlined and all other nucleotides are 2’-
deoxy: 2’OMe anti, 5’-CUGACCCUGAAGUUCAUCUGCACCL-3’; 2’OMe rev, 5’-
CCACGUCUACUUGAAGUCCCAGUCL-3’; deoxy anti, 5’-CTGACCCTGAAGTTCA 
TCTGCACCGCGL-3’. Oligonucleotides were cotransfected with the designated shRNA 
plasmid (500 ng) into HEK293T tTA-d2EGFP cells seeded in a 12-well plate using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions with a final 
oligo concentration of 50 nM. The media was replaced one day post-transfection and the 
cells were trypsinized and assayed by flow cytometry three days post-transfection. Only 
transfected cells were included in the analysis based upon high DsRed-Express 
expression levels. A separate shRNA (sh’) that targets the EGFP mRNA in a different 
location was included in the analysis. 
 
qRT-PCR. The following oligos were used for qRT-PCR against La protein (Acc # 
X13697) and the loading control GAPDH (Acc # NM_002046): La_fwd, 5’-
GGTTGAACCGTCTAACAACAG-3’; La_rev, 5’-ATGTCATCAAGAGTTGCATCAG-
3’; GAPDH_fwd, 5’-GAAGGTGAAGGTCGGAGTC-3’; GAPDH_rev, 5’-GAAGATG 
GTGATGGGATTTC-3’. HEK293T tTA-d2EGFP cells were transfected in a 12-well 
plate in the presence or absence of 1.5 mM theophylline with plasmids harboring the 
hygromycin B resistance gene and an shRNA targeting La protein mRNA (Acc # 
X13697). shRNA sequences are contained in Supplementary Table I. One day post-
transfection, cells were subcultured and seeded into a 6-well plate. One day later, the 
media was replaced and supplemented with 300 µg/ml puromycin. Four days after adding 
hygromycin, dead cells were removed with a 1X PBS wash and total RNA was extracted 
using the RNeasy Protect Mini kit (Qiagen) according to the manufacturer’s instructions 
and DNase I-treated for 20 minutes at 37°C. Following purification using a NucAway 
column (Ambion), total RNA (up to 5 µg) was reverse-transcribed using Superscript III 
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reverse transcriptase (Invitrogen) according to the manufacturer’s instructions using the 
gene-specific reverse primers for La protein and GAPDH followed by the recommended 
incubation with RNase H. qRT-PCR was conducted with this cDNA on the iCycler iQ 
system (BioRAD) according to the manufacturer’s instructions. Samples were prepared 
in quadruplicate using the iQ SYBR green supermix and data were analyzed using the 
iCycler iQ software. 
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